Key Highlights
- Jay Harger, PhD, promoted to Chief Operating Officer, leading global operations including facilities, manufacturing, and supply chain.
- Mike Stubbington, PhD, named Chief Scientific Officer, overseeing global research and development and serving as UK site head.
- CS Genetics prepares for first commercial launch of their single-cell genomics platform.
Source: PR Newswire
Notable Quote
- “Mike and Jay’s leadership will be catalytic as we shift attention to our commercial launch. Their promotions are hugely well-deserved, and their leadership in these new roles will continue to be catalytic as we now shift attention to our first commercial launch.” — Luke Edelman, Founder, Board Member, and CTO at CS Genetics
SoHC's Take
The promotion of Jay Harger and Mike Stubbington to COO and CSO, respectively, marks a pivotal moment for CS Genetics as the company transitions from development to commercialization of its groundbreaking single-cell genomics platform. Harger’s extensive experience at Illumina and Stubbington’s expertise in single-cell technologies position CS Genetics strongly as it enters a competitive market. Their leadership is expected to play a crucial role in driving the company’s success and expanding the reach of single-cell genomics to new and underserved segments.
